Product Information
VANCOMYCIN HCL 5 GM VIAL is a generic product labeled by Fresenius Kabi USA, LLC, priced at $39.3160 per EA under NDC 63323029561. Its NADAC has been published 262 times since Nov 28, 2013.
FDA first approved this application on Mar 17, 1987. Its Orange Book therapeutic-equivalence code is AP.
The High Outlier badge above means this manufacturer's average price in the VANCOMYCIN HYDROCHLORIDE market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
5 g/100mL
Manufacturer
Fresenius Kabi USA, LLCNDC
63323029561
Classification
Generic
Dosage Form
INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Route
INTRAVENOUS
Effective Date
9/18/2024
Active Ingredients
VANCOMYCIN HYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA062663FDA Approved
3/17/1987
TE Code
AP
On Market Since
7/17/2001
Pharmacological Classes
Price Statistics
The NADAC for VANCOMYCIN HCL 5 GM VIAL has been published 262 times since Nov 28, 2013, and over the history we have for it it has risen 46.3%. The table below summarizes its recorded NADAC range and movement.
| Current price | $39.3160 per EA |
|---|---|
| All-time high | $46.2871 (Mar 11, 2015) |
| All-time low | $17.5080 (Aug 19, 2015) |
| 52-week high | $39.3160 |
| 52-week low | $39.3160 |
| Median price | $27.2371 |
| Average price | $28.2541 |
| Largest weekly change | +88.5% (Feb 18, 2015) |
| Weeks tracked | 262 |
| Tracking since | Nov 28, 2013 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
0.0%
3Y
+38.9%
5Y
+38.9%
All
+46.3%
Last surveyed Sep 10, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of VANCOMYCIN HCL 5 GM VIAL?
The current National Average Drug Acquisition Cost (NADAC) for VANCOMYCIN HCL 5 GM VIAL, manufactured by Fresenius Kabi USA, LLC, is $39.3160 per EA (NDC 63323029561), effective Sep 10, 2025.
How has the price of VANCOMYCIN HCL 5 GM VIAL changed over time?
Over the history we have for it, the NADAC for VANCOMYCIN HCL 5 GM VIAL has risen 46.3%. It has been tracked across 262 weekly CMS publications since Nov 28, 2013.
What are the highest and lowest recorded NADAC prices for VANCOMYCIN HCL 5 GM VIAL?
Since Nov 28, 2013, the NADAC for VANCOMYCIN HCL 5 GM VIAL has ranged from a low of $17.5080 (Aug 19, 2015) to a high of $46.2871 (Mar 11, 2015), with a median of $27.2371 per EA.
Are there cheaper alternatives to VANCOMYCIN HCL 5 GM VIAL?
2 manufacturers publish a NADAC-priced product with the same active ingredient and strength as VANCOMYCIN HCL 5 GM VIAL in a comparable dosage form, but none are currently priced below it.
Who manufactures VANCOMYCIN HCL 5 GM VIAL?
VANCOMYCIN HCL 5 GM VIAL (NDC 63323029561) is labeled by Fresenius Kabi USA, LLC, and CMS classifies it as a generic product.